The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform

Chemistry and Biology

Volumn 14, Issue 1, 2007, Pages 107-115

  Hong, Seungpyo ^a,b   Leroueil, Pascale R ^a,b   Majoros, István J ^b   Orr, Bradford G ^a,b   Baker Jr , James R ^b   Banaszak Holl, Mark M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CHEMBIOL

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DENDRIMER; DRUG CARRIER; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; METABOLISM; PROTEIN BINDING; SURFACE PLASMON RESONANCE; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL LINE, TUMOR; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; FOLIC ACID; HUMANS; NANOPARTICLES; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SURFACE PLASMON RESONANCE;

EID: 33846312153     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2006.11.015     Document Type: Article

References (43)

1. Hilgenbrink A.R., and Low P.S. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci. 94 (2005) 2135-2146
2. Lu Y.J., and Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54 (2002) 675-693
3. Salmaso S., Semenzato A., Caliceti P., Hoebeke J., Sonvico F., Dubernet C., and Couvreur P. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate. Bioconjug. Chem. 15 (2004) 997-1004
4. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., Hoebeke J., Duguet E., Colombo P., and Couvreur P. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem. 16 (2005) 1181-1188
5. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebeke J., Renoir M., D'Angelo J., Cattel L., and Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89 (2000) 1452-1464
6. Quintana A., Raczka E., Piehler L., Lee I., Myc A., Majoros I., Patri A.K., Thomas T., Mule J., and Baker J.R. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm. Res. 19 (2002) 1310-1316
7. Kiessling L.L., Gestwicki J.E., and Strong L.E. Synthetic multivalent ligands as probes of signal transduction. Angew. Chem. Int. Ed. Engl. 45 (2006) 2348-2368
8. Lee R.T., and Lee Y.C. Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconj. J. 17 (2000) 543-551
9. Lee Y.C., and Lee R.T. Carbohydrate-protein interactions-basis of glycobiology. Acc. Chem. Res. 28 (1995) 321-327
10. Mammen M., Choi S.K., and Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. Engl. 37 (1998) 2755-2794
11. Metallo S.J., Kane R.S., Holmlin R.E., and Whitesides G.M. Using bifunctional polymers presenting vancomycin and fluorescein groups to direct anti-fluorescein antibodies to self-assembled monolayers presenting D-alanine-D-alanine groups. J. Am. Chem. Soc. 125 (2003) 4534-4540
12. Mourez M., Kane R.S., Mogridge J., Metallo S., Deschatelets P., Sellman B.R., Whitesides G.M., and Collier R.J. Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19 (2001) 958-961
13. Seeberger P.H., and Werz D.B. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat. Rev. Drug Discov. 4 (2005) 751-763
14. Christensen T., Gooden D.M., Kung J.E., and Toone E.J. Additivity and the physical basis of multivalency effects: a thermodynamic investigation of the calcium EDTA interaction. J. Am. Chem. Soc. 125 (2003) 7357-7366
15. Reuter J.D., Myc A., Hayes M.M., Gan Z.H., Roy R., Qin D.J., Yin R., Piehler L.T., Esfand R., Tomalia D.A., et al. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug. Chem. 10 (1999) 271-278
16. Kitov P.I., and Bundle D.R. On the nature of the multivalency effect: a thermodynamic model. J. Am. Chem. Soc. 125 (2003) 16271-16284
17. Gestwicki J.E., Cairo C.W., Mann D.A., Owen R.M., and Kiessling L.L. Selective immobilization of multivalent ligands for surface plasmon resonance and fluorescence microscopy. Anal. Biochem. 305 (2002) 149-155
18. Rao J.H., Lahiri J., Isaacs L., Weis R.M., and Whitesides G.M. A trivalent system from vancomycin center dot D-Ala-D-Ala with higher affinity than avidin·biotin. Science 280 (1998) 708-711
19. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in-vivo and in established cell-lines-physiological and clinical implications. Cancer 73 (1994) 2432-2443
20. Weitman S.D., Weinberg A.G., Coney L.R., Zurawski V.R., Jennings D.S., and Kamen B.A. Cellular-localization of the folate receptor-potential role in drug toxicity and folate homeostasis. Cancer Res. 52 (1992) 6708-6711
21. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., and Kamen B.A. Distribution of the folate receptor gp38 in normal and malignant-cell lines and tissues. Cancer Res. 52 (1992) 3396-3401
22. Campbell I.G., Jones T.A., Foulkes W.D., and Trowsdale J. Folate-binding protein is a marker for ovarian-cancer. Cancer Res. 51 (1991) 5329-5338
23. Leamon C.P., and Low P.S. Selective targeting of malignant-cells with cytotoxin-folate conjugates. J. Drug Target. 2 (1994) 101-112
24. Leamon C.P., and Reddy J.A. Folate-targeted chemotherapy. Adv. Drug Deliv. Rev. 56 (2004) 1127-1141
25. Roy E.J., Gawlick U., Orr B.A., and Kranz D.M. Folate-mediated targeting of T cells to tumors. Adv. Drug Deliv. Rev. 56 (2004) 1219-1231
26. Stephenson S.M., Low P.S., and Lee R.J. Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol. 387 (2004) 33-50
27. Kranz D.M., Patrick T.A., Brigle K.E., Spinella M.J., and Roy E.J. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor-cells for lysis. Proc. Natl. Acad. Sci. USA 92 (1995) 9057-9061
28. Patri A.K., Majoros I.J., and Baker J.R. Dendritic polymer macromolecular carriers for drug delivery. Curr. Opin. Chem. Biol. 6 (2002) 466-471
29. Kukowska-Latallo J.F., Candido K.A., Cao Z.Y., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., and Baker J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65 (2005) 5317-5324
30. Majoros I.J., Thomas T.P., Mehta C.B., and Baker J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 48 (2005) 5892-5899
31. Hong S., Bielinska A.U., Mecke A., Keszler B., Beals J.L., Shi X.Y., Balogh L., Orr B.G., Baker J.R., and Banaszak Holl M.M. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug. Chem. 15 (2004) 774-782
32. Hong S., Leroueil P.R., Janus E.K., Peters J.L., Kober M.-M., Islam M.T., Orr B.G., Baker J.R., and Banaszak Holl M.M. The interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug. Chem. 17 (2006) 728-734
33. Islam M.T., Majoros I.J., and Baker J.R. HPLC analysis of PAMAM dendrimer based multifunctional devices. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 822 (2005) 21-26
34. Mecke A., Lee I., Baker J.R., Holl M.M.B., and Orr B.G. Deformability of poly(amidoamine) dendrimers. Eur. Phys. J. E 14 (2004) 7-16
35. Kane M.A., Elwood P.C., Portillo R.M., Antony A.C., Najfeld V., Finley A., Waxman S., and Kolhouse J.F. Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human-cells. J. Clin. Invest. 81 (1988) 1398-1406
36. Shaunak S., Thomas S., Gianasi E., Godwin A., Jones E., Teo I., Mireskandari K., Luthert P., Duncan R., Patterson S., et al. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat. Biotechnol. 22 (2004) 977-984
37. Thomas T.P., Majoros I.J., Kotlyar A., Kukowska-Latallo J.F., Bielinska A., Myc A., and Baker J.R. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem. 48 (2005) 3729-3735
38. Thomas T.P., Patri A.K., Myc A., Myaing M.T., Ye J.Y., Norris T.B., and Baker J.R. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules 5 (2004) 2269-2274
39. Holm J., Hansen S.I., Hoier-Madsen M., Birn H., and Helkjaer P.E. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. Arch. Biochem. Biophys. 366 (1999) 183-191
40. Majoros I.J., Keszler B., Woehler S., Bull T., and Baker J.R. Acetylation of poly(amidoamine) dendrimers. Macromolecules 36 (2003) 5526-5529
41. Choi Y., Thomas T., Kotlyar A., Islam M.T., and Baker J.R. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem. Biol. 12 (2005) 35-43
42. Nygren-Babol L., Sternesjo A., Jagerstad M., and Bjorck L. Affinity and rate constants for interactions of bovine folate-binding protein and folate derivatives determined by optical biosensor technology. Effect of stereoselectivity. J. Agric. Food Chem. 53 (2005) 5473-5478
43. Glaser R.W. Antigen-antibody binding and mass-transport by convection and diffusion to a surface-a 2-dimensional computer-model of binding and disscociation kinetics. Anal. Biochem. 213 (1993) 152-161